| CYTX Market Cap History Table | ||||||||||||
Below is a table of the CYTX market cap history going back to 5/24/2018:
Also see: CYTX Shares Outstanding History and CYTX YTD Return |
As of 4/30/2019 Cytori Therapeutics has a market cap of 6.65 million. Investors often follow the CYTX market cap history to compare the size of the company over time.
This page shows CYTX market capitalization trends over time, with 5 market cap datapoints presented, dating back to 5/24/2018.

| CYTX Market Cap History Table | ||||||||||||
Below is a table of the CYTX market cap history going back to 5/24/2018:
Also see: CYTX Shares Outstanding History and CYTX YTD Return |
| CYTX Market Cap History Chart | |||||||||||||||
CYTX Historical Market Cap: -58.73% CAGR
Mouse over chart for data details
| |||||||||||||||
| CYTX Stock Price Chart |
| About Plus Therapeutics Inc |
| Cytori Therapeutics develops regenerative and oncologic therapies from its proprietary cell therapy and nanoparticle platforms for various medical conditions. Co.'s drug candidates at its Cytori Nanomedicine platform include: ATI-0918, which is its primary drug candidate and a generic version of pegylated liposomal encapsulated doxorubicin; and ATI-1123, a chemical entity which is a nanoparticle-encapsulated form of docetaxel, also a workhorse chemotherapeutic drug used for various cancers. Co.'s product candidates at its Cytori Cell Therapy platform include Habeo Cell Therapy, which is its primary product candidate for the treatment of impaired hand function in patients with scleroderma. We show 5 historical shares outstanding datapoints in our CYTX shares outstanding history coverage, used to compute CYTX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CYTX market cap history over the course of time is important for investors interested in comparing CYTX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CYTX versus a peer is one thing; comparing CYTX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CYTX can fluctuate over the course of history. With this page we aim to empower investors researching CYTX by allowing them to research the CYTX market cap history. |
| CYTX Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| CYTX Share Performance |
| Market Cap Peers |
| Cytori Therapeutics (CYTX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
DARE Market Cap History DAWN Market Cap History DBTX Market Cap History DCGO Market Cap History DCOY Market Cap History DCPH Market Cap History DCTH Market Cap History DEPO Market Cap History DERM Market Cap History DFFN Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.